ExcepGen Emerges From Stealth with New Funding for its Nucleic Acid Therapeutics Platform

SAN FRANCISCO, Aug. 24, 2023 /PRNewswire/ — ExcepGen, a genetic medicine startup, emerged from stealth after the successful completion of its newest funding round. The most recent $4 million round, which brings the company’s total seed funding to $14 million, was led by RA Capital…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.